FUJIFILM Diosynth Biotechnologies begins production of two COVID-19 vaccines

▴ FUJIFILM Diosynth Biotechnologies begins production of two COVID-19 vaccines
FUJIFILM Diosynth Biotechnologies announced that production has begun in Texas on two different COVID-19 vaccine candidates with support from the U.S. government

FUJIFILM Diosynth Biotechnologies and the Texas A&M University System Center for Innovation in Advanced Development & Manufacturing (CIADM) announced that production has begun in Texas on two different COVID-19 vaccine candidates with support from the U.S. government to meet Operation Warp Speed goals.

FUJIFILM Diosynth Biotechnologies Texas, a subcontractor of the CIADM, recently completed its capacity expansion at its Flexible Biomanufacturing Facility in College Station, Texas, to accommodate large-scale production of the COVID-19 vaccine candidates. FUJIFILM Diosynth Biotechnologies will produce bulk drug substance of NVX?CoV2373, Novavax’ vaccine candidate, which began phase 3 clinical testing in the U.S. and Mexico in December, 2020. NVX-CoV2373- is already being manufactured at commercial scale at the company’s plant in Morrisville, North Carolina.

“After several months of intense preparation and hard work, we are ready to produce two vaccine candidates locally here in College Station,” said Dr Gerry Farrell, Chief Operating Officer, FUJIFILM Diosynth Biotechnologies, Texas. “We are pleased to bring our technical expertise and world-class facilities to support the mission of Operation Warp Speed in bringing a safe and effective vaccine to the world.”

“The Texas A&M System is proud to be part of this unprecedented manufacturing effort,” said John Sharp, Chancellor of The Texas A&M System. “Our partnership with FUJIFILM Diosynth Biotechnologies confirms the importance of the CIADM program for Texas, the nation and the world.”

FUJIFILM Diosynth Biotechnologies owns and operates three facilities built through the CIADM program. As a subcontractor of the Texas A&M System, the facilities can be made available for emergency government use.

In July, the federal government reserved capacity at the College Station facility through the end of 2021 by tapping into an agreement with the CIADM. To enhance vaccine production, FUJIFILM Diosynth Biotechnologies accelerated its planned capacity expansion investments in the facility by several months. The facility is the largest scale-out cell culture manufacturing facility in the U.S. with a total of 14 2,000L cell culture trains.

To prepare for mass production of the vaccine candidates, FUJIFILM Diosynth Biotechnologies has added about 260 positions since April 2020, doubling its local workforce. The company plans to recruit another 50 positions.

“Our team has worked around the clock since July and we’re starting to see light at the end of the tunnel,” Farrell said. “There is great pride and satisfaction on our team for being part of the solution to the pandemic.”

The CIADM contract is with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services (HHS).

“This is a tremendous responsibility,” said Dr W. Jay Treat, Texas A&M’s Chief Manufacturing Officer for the CIADM. “It’s gratifying for us to make a positive contribution in fighting the pandemic.”

Operation Warp Speed is a partnership among components of the HHS, the Department of Defense and other federal agencies, engaging with private firms, and coordinating among existing HHS-wide efforts to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics.

Tags : #FUJIFILMDiosynthBiotechnologies #LatestNewsonFUJIFILMDiosynthBiotechnologies #LatestPharmaNews19thJan #USGovernment #LatestNewsonCOVIDVaccine #BARDA

About the Author


Team Medicircle

Related Stories

Loading Please wait...
-Advertisements-


Trending Now

Behavioral Changes Towards Innovation in Technology is the Need of the Hour, says Bitopan Sarma Baruah, Head IT and Business Process, Excelcare HospitalsMarch 08, 2021
6 Top Women Entrepreneurs and CXOs are Transforming Healthcare for the BetterMarch 06, 2021
Top 4 reasons to visit a dentist today March 06, 2021
“Reframe your thoughts to prevent Dissociative Identity Disorder (DID)” by Dr.Sheereen K Bajpai, Expert Psychologist & Counselor from Indian Institute of Science Education and ResearchMarch 06, 2021
Digitalization Should Enable Clinicians to Focus on The Human Touch, says Dr. George Fernandes, CEO, Viveka HospitalsMarch 05, 2021
March 5 th 2021- Dissociative Identity Disorder(DID) Awareness DayMarch 04, 2021
Are You Struggling with “Maskne”? Find the Top 5 Solutions to deal with it. March 03, 2021
Exercise could well mimic the effects of Polypill , also it's cheaper and without side effectsMarch 03, 2021
Sorrento receives USFDA clearance to start a clinical trial of Anti-CD47 antibodyMarch 03, 2021
Regular breast checks by trained health workers linked to fewer breast cancer deaths in IndiaMarch 03, 2021
Treat Doctors as Friends and Have an Open Chat with Them says Dr. Shailaja Sabnis, Consultant Physician and Rheumatologist March 03, 2021
PM Jan Aushadhi Kendra inaugurated at District Hospital, KargilMarch 02, 2021
Maharashtra records 6,397 new cases of coronavirus todayMarch 02, 2021
One in four people will have hearing problems by 2050: WHOMarch 02, 2021
6 states show surge in Covid-19 cases, India's total active cases reach 1,68,627March 02, 2021
hday for longer life ; American Heart AssociationMarch 02, 2021
Is your baby cranky due to skin complaints? Here are some quick solutions that can help you.March 02, 2021
Women Have the Right to Say “No”, says Dr. Vaishali Joshi, Senior Obstetrician & Gynaecologist, Kokilaben Ambani Hospital, MumbaiMarch 02, 2021
How to Control STDs, explains, Dr. Nikul Patel, Founder and Chief Ayurveda Consultant of Atharva Ayurveda Clinic and Panchakarma Center March 02, 2021
Registration for next phase of COVID19 Vaccination on Co-WIN2.0 portal will open at 9:00 am on 1st MarchMarch 01, 2021